Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Baricitinib bulk supplier for pharma manufacturers

Baricitinib 2 mg, 4 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 2 mg, 4 mg

Reference Brands: Olumiant®(EU & US- Emergency Use Authorization (EUA)

Category: Anti Covid Medicines

Baricitinib (Olumiant®) is a JAK inhibitor used for rheumatoid arthritis and COVID-19 treatment in hospitalized adults, approved in the US and EU. Available in 1 mg, 2 mg, and 4 mg tablets, it’s sourced globally via PharmaB2B platforms. Connect with GMP-certified manufacturers offering Baricitinib for bulk supply, tenders, and institutional procurement, with full regulatory documentation and global export support.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Baricitinib, marketed as Olumiant® by Eli Lilly, is a JAK inhibitor approved in the US and EU for rheumatoid arthritis and authorized for COVID-19 treatment in hospitalized adults. Available in 1 mg, 2 mg, and 4 mg oral tablets, it helps reduce inflammation and cytokine storms in severe COVID-19 cases. Through leading PharmaB2B platforms, global buyers can source Olumiant or Baricitinib generics from GMP-certified manufacturers in India, China, and Bangladesh. Ideal for hospital tenders and bulk procurement, Baricitinib is widely distributed with full regulatory support, competitive pricing, and fast international shipping.

Baricitinib — third party manufacturing & bulk supply

Baricitinib 2 mg, 4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Baricitinib is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Baricitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Baricitinib →
Back to Listing

Frequently Asked Questions

Baricitinib is listed as Tablet in 2 mg, 4 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Baricitinib is referenced against Olumiant®(EU & US- Emergency Use Authorization (EUA). Reference brands are shown for identification only and remain the property of their respective trademark owners.

Related Products

Nirmatrelvir / Ritonavir Tablet

Strength:
Nirmatrelvir(150 mg) + Ritonavir(100 mg)

Form: Tablet

Reference Brands: Paxlovid®(US & EU- For Emergency Use Authorization)

View Details
Tocilizumab

Strength:
IV: 80 mg/4 mL, 200 mg/10 mL, 400 mg/20 mL; SQ: 162 mg/0.9 mL (pen or syringe)

Form: IV injection, SQ Injection

Reference Brands: Actemra®(US); RoActemra®(EU)

View Details
Molnupiravir

Strength:
200 mg

Form: Oral capsule

Reference Brands: Lagevrio®(Us & EU)

View Details
Favipiravir Tablet

Strength:
200 mg, 400 mg, 600 mg

Form: Tablet

Reference Brands: Fabiflu, Favicovid, Covihalt, Avifavir, Avigan, Favira , Favilow(Globally, Not approved in USA & EU)

View Details
Remdesivir

Strength:
Powder(100 mg/vial); Injection: 100 mg/20 mL (5 mg/mL)

Form: Lyophilized powder for IV & Injection

Reference Brands: Veklury® (EU & US)

View Details
Enquire Now

Quick Response Guaranteed | Verified Suppliers

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.